Perspective on the EF-14 trial and its implications for the role of tumor-treating fields in the management of glioblastoma



Mohan, S, Chawla, S, Skolnik, A and Poptani, H ORCID: 0000-0002-0593-3235
(2016) Perspective on the EF-14 trial and its implications for the role of tumor-treating fields in the management of glioblastoma TRANSLATIONAL CANCER RESEARCH, 5 (S2). S272-S275. ISSN 2218-676X, 2219-6803

[thumbnail of Perspective TCR_final.docx] Text
Perspective TCR_final.docx - Author Accepted Manuscript

Download (70kB)

Abstract

Tumor-treating fields (TTFields) is a novel treatment modality that has been recently approved for the treatment of patients with both newly diagnosed and recurrent glioblastoma multiforme (GBM). This approach comprises of a portable device delivering low intensity and intermediate frequency alternating electric fields aiming at selectively inhibiting cellular proliferation of neoplastic cells. Promising findings of recent large scale multinational clinical trials have indicated that TTFields have a favorable safety profile without causing significant adverse effects on patients. One of these trials reported that GBM patients treated with TTFields had significantly prolonged overall and progression free survival (PFS) compared to patients receiving standard chemotherapy. Moreover, improved quality of life with better cognitive and emotional functions was observed in TTFields treated cohorts of patients. Conventional MR imaging using modified RANO criteria is currently considered as the standard protocol for assessing disease progression and treatment response in patients with GBM. Using physiological and metabolic MR imaging, we recently reported our experience with evaluating treatment response to TTFields in newly diagnosed GBM. We believe that additional studies evaluating the treatment response of TTFields will have a profound impact on the clinical use of this novel and effective treatment modality for GBM patients.

Item Type: Article
Uncontrolled Keywords: Tumor-treating fields (TTFields), glioblastoma, diffusion tensor imaging (DTI), proton MR spectroscopy
Depositing User: Symplectic Admin
Date Deposited: 07 Nov 2016 07:56
Last Modified: 07 Dec 2024 09:05
DOI: 10.21037/tcr.2016.07.49
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3004385
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.